IT & Data Management
IT & Data Management
Overcoming Counterfeit Challenges With Blockchain In Pharma
Researchers from Sweden have identified the advantages of employing smart contracts on blockchain platforms within the pharmaceutical supply chain to combat counterfeit drugs. Despite the estimated value of the counterfeit market exceeding $200 billion and the numerous benefits it...
IT & Data Management
Digital Maturity – Evolving Pharmaceutical Supply Chains
Global pharmaceutical companies have faced significant scrutiny for various issues, such as inconsistent drug availability, a lack of transparency in environmental, social, and governance practices, and a surge in counterfeit medications. This increased scrutiny indicates that the traditional manufacturing...
IT & Data Management
Blockchain Technology And Quality Control In Pharma Industry
In late 2020, Pfizer, a drug manufacturer, faced challenges in meeting its Covid-19 vaccine production targets due to quality issues with raw materials, causing disruptions in the global supply chain. The situation worsened in March 2021 when contamination issues...
IT & Data Management
FDA Discussion Paper On AI And ML Aiming Drug Development
A discussion paper has been published by the US FDA that aims at complementing and informing future guidance on artificial intelligence (AI) and machine learning (ML) usage in drug development. The purpose of this paper is to initiate an...
IT & Data Management
AARDEX Group Partners with Industry Leaders on DiMe’s V3+ Framework Project to Enhance Usability of DHTs
Adherence specialists AARDEX Group are proud to announce its partnership with other industry leaders on DiMe’s new Extending the Verification, Analytical Validation, and Clinical Validation (V3+) Framework project.
Organizations are taking digital clinical measures and products to scale, meaning digital...
IT & Data Management
Blockchain Revolutionizes Pharma Operations And Profits
The pharmaceutical sector happens to be significant for enhancing and sustaining public health. It is responsible when it comes to exploring, developing, producing, as well as marketing drugs and other pharmaceutical products. That said, it faces loads of challenges...
IT & Data Management
Digital Bioprocessing Is Set To Improve Drug Product Quality
One of the market reports has gone on to show that the digital biomanufacturing segment is expected to grow at a CAGR of 11% between 2023 and 2035 and will be driven largely by digital transformation.
The influencing factors identified...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read